Qiagen NV | QIA - 贷款资金

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.31B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	贷款资金	更改		日
Akebia Therapeutics	USD 24.75M		11.64M	2026-06
Alaunos Therapeutics	USD 4.47M		5.85M	2022-06
argenx SE	USD 36M		432K	2026-06
Avita Medical	AUD 42.24M		1.25M	2024-12
Dianthus Therapeutics	USD 0		0	2024-12
Ionis Pharmaceuticals	USD 1.91B		6.62M	2026-06
IQVIA Holdings	USD 13.7B		284M	2026-06
Moderna	USD 597M		6M	2026-06
Organon & Co	USD 8.48B		74M	2026-06
Qiagen NV	USD 1.63B		19.45M	2026-06
Revvity	USD 2.63B		1.02M	2026-06
Tectonic Therapeutic	USD 17K		26K	2026-03
Viatris	USD 11.61B		801.1M	2026-06
Xeris Pharmaceuticals	USD 188.81M		32.42M	2026-06